View in EDS PDF Full Text

Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.

Saved in:
Bibliographic Details
Title: Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
Authors: Kobayashi RH; UCLA School of Medicine, Los Angeles, CA, USA., Litzman J; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia., Melamed I; IMMUNOe Research Center, Centennial, CO, USA., Mandujano JF; Pediatric Pulmonary Associates of North Texas, Frisco, TX, USA., Kobayashi AL; Midlands Pediatrics, Papillion, NE, USA., Ritchie B; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada., Geng B; Divisions of Allergy and Immunology, University of California San Diego, La Jolla, CA, USA., Atkinson TP; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, USA., Rehman S; Allergy and Asthma Center Inc., Toledo, OH, USA., Höller S; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria., Turpel-Kantor E; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria., Kreuwel H; Octapharma US, Paramus, NJ, USA., Speer JC; Octapharma US, Paramus, NJ, USA., Gupta S; Division of Basic and Clinical Immunology, University of California Irvine, Irvine, CA, USA.
Source: Clinical and experimental immunology [Clin Exp Immunol] 2022 Dec 15; Vol. 210 (2), pp. 91-103.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36208448
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kobayashi+RH%22">Kobayashi RH</searchLink>; UCLA School of Medicine, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Litzman+J%22">Litzman J</searchLink>; Department of Clinical Immunology and Allergology, St Anne's University Hospital in Brno, Faculty of Medicine, Masaryk University, Brno, Czechia.<br /><searchLink fieldCode="AU" term="%22Melamed+I%22">Melamed I</searchLink>; IMMUNOe Research Center, Centennial, CO, USA.<br /><searchLink fieldCode="AU" term="%22Mandujano+JF%22">Mandujano JF</searchLink>; Pediatric Pulmonary Associates of North Texas, Frisco, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kobayashi+AL%22">Kobayashi AL</searchLink>; Midlands Pediatrics, Papillion, NE, USA.<br /><searchLink fieldCode="AU" term="%22Ritchie+B%22">Ritchie B</searchLink>; Division of Hematology, Department of Medicine, University of Alberta Hospital, Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Geng+B%22">Geng B</searchLink>; Divisions of Allergy and Immunology, University of California San Diego, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Atkinson+TP%22">Atkinson TP</searchLink>; Department of Pediatric Allergy, Asthma and Immunology, University of Alabama, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Rehman+S%22">Rehman S</searchLink>; Allergy and Asthma Center Inc., Toledo, OH, USA.<br /><searchLink fieldCode="AU" term="%22Höller+S%22">Höller S</searchLink>; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Turpel-Kantor+E%22">Turpel-Kantor E</searchLink>; Octapharma Pharmazeutika Produktionsges.m.b.H., Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kreuwel+H%22">Kreuwel H</searchLink>; Octapharma US, Paramus, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Speer+JC%22">Speer JC</searchLink>; Octapharma US, Paramus, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Gupta+S%22">Gupta S</searchLink>; Division of Basic and Clinical Immunology, University of California Irvine, Irvine, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2022 Dec 15; Vol. 210 (2), pp. 91-103.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36208448
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/cei/uxac092
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 91
    Titles:
      – TitleFull: Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kobayashi RH
      – PersonEntity:
          Name:
            NameFull: Litzman J
      – PersonEntity:
          Name:
            NameFull: Melamed I
      – PersonEntity:
          Name:
            NameFull: Mandujano JF
      – PersonEntity:
          Name:
            NameFull: Kobayashi AL
      – PersonEntity:
          Name:
            NameFull: Ritchie B
      – PersonEntity:
          Name:
            NameFull: Geng B
      – PersonEntity:
          Name:
            NameFull: Atkinson TP
      – PersonEntity:
          Name:
            NameFull: Rehman S
      – PersonEntity:
          Name:
            NameFull: Höller S
      – PersonEntity:
          Name:
            NameFull: Turpel-Kantor E
      – PersonEntity:
          Name:
            NameFull: Kreuwel H
      – PersonEntity:
          Name:
            NameFull: Speer JC
      – PersonEntity:
          Name:
            NameFull: Gupta S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 12
              Text: 2022 Dec 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2249
          Numbering:
            – Type: volume
              Value: 210
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical and experimental immunology
              Type: main
ResultId 1